A case study of a long-term glioblastoma survivor with unmethylated MGMT and hypermutated genotype

Effective treatments that extend survival of malignant brain tumor glioblastoma (GBM) have not changed in more than a decade; however, there exists a minority patient group (<5%) whose survival is longer than 3 yr. We herein present a case report of a long-term surviving 51-yr-old female diagnose...

Descripción completa

Detalles Bibliográficos
Autores principales: Jue, Toni Rose, Olafson, Lauren R., Siddell, Anna H., Rapkins, Robert W., Ng, Benedict, Yin, Julia X.M., Lu, Victor M., Chung, Sylvia A., Whittaker, Shane P., Davies, Matthew, Fairhall, Jacob M., Hovey, Elizabeth J., McDonald, Kerrie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2019
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549560/
https://www.ncbi.nlm.nih.gov/pubmed/31160353
http://dx.doi.org/10.1101/mcs.a003251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549560/
https://www.ncbi.nlm.nih.gov/pubmed/31160353
http://dx.doi.org/10.1101/mcs.a003251

Ejemplares similares